On January 14, the Federal Trade Commission (“FTC”) published its Second Interim Staff Report (“Report”) on pharmacy benefit managers (“PBMs”), focusing on PBM pricing practices for specialty generic drugs. The Report described significant markups of cancer, HIV and other chronic condition specialty drugs and high reimbursement rates paid by Caremark Rx, Express Scripts and... READ MORE
FTC Releases Second Interim Staff Report on Pharmacy Benefit Managers
Posted on January 29, 2025 in Health Law News
Published by: Hall Render
